Upregulated E3 ligase tripartite motif‐containing protein 21 in psoriatic epidermis ubiquitylates nuclear factor‐κB p65 subunit and promotes inflammation in keratinocytes*
- 30 March 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 184 (1), 111-122
- https://doi.org/10.1111/bjd.19057
Abstract
Background Tripartite motif‐containing protein 21 (Trim21) is an E3 ubiquitin‐protein ligase that plays pivotal roles in various diseases. However, its role in mediating keratinocyte inflammation, which is a hallmark of psoriasis, has not been thoroughly elucidated. Objectives To clarify whether Trim21 plays a pivotal role in regulating keratinocyte inflammation in psoriasis, while focusing on identifying key Trim21 substrates involved in mediating proinflammatory cytokine and chemokine production. Methods Cytokine and chemokine secretion was examined by quantitative real‐time PCR (qPCR) in Trim21‐knockdown human keratinocytes. Downstream pathways and substrates of Trim21 were evaluated using immunoblotting, immunoprecipitation and immunofluorescence. The influence of Trim21 ubiquitination on its substrates was tested by in vitro ubiquitination assay, immunoprecipitation and immunofluorescence. The effectiveness of targeting Trim21 for psoriasis treatment was assessed in vivo with haematoxylin and eosin (H&E) staining, immunofluorescence and qPCR. Results Knocking down Trim21 expression alleviated keratinocyte inflammation. Trim21 colocalized with p65/Nuclear factor‐κB (NF‐κB) in the cytosol and physically bound and ubiquitinated p65 via a lysine 63 (K63) linkage. Instead of changing p65 protein stability, Trim21 enhanced the interaction of p65 with IκB kinase (IKK), which promoted p65 phosphorylation, nuclear transport and downstream gene activation. Finally, both in vitro and in vivo experiments verified that topical application of Trim21‐specific small interfering RNA (siRNA) markedly ameliorated imiquimod (IMQ)‐induced psoriasis‐like lesions. Conclusions Our study confirms that upregulated Trim21 in psoriatic epidermis ubiquitylates p65 and activates the NF‐κB pathway, which promotes keratinocyte inflammation. Hence, Trim21 represents a potential target for psoriasis treatment.Funding Information
- National Natural Science Foundation of China (81602749, 81673051, 81430073)
This publication has 45 references indexed in Scilit:
- NF-κB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in GlioblastomaPLOS ONE, 2013
- Stat3 Inhibition Attenuates Mechanical Allodynia through Transcriptional Regulation of Chemokine Expression in Spinal AstrocytesPLOS ONE, 2013
- The complexity of NF-κB signaling in inflammation and cancerMolecular Cancer, 2013
- Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in gliomaOncogene, 2012
- Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus ErythematosusInternational Journal of Rheumatology, 2012
- Downregulation of active IKKβ by Ro52-mediated autophagyMolecular Immunology, 2010
- Respiratory Syncytial Virus-Mediated NF-κB p65 Phosphorylation at Serine 536 Is Dependent on RIG-I, TRAF6, and IKKβJournal of Virology, 2010
- Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23–Th17 pathwayThe Journal of Experimental Medicine, 2009
- Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-κB-Dependent Cytokine Expression in FibroblastsThe Journal of Immunology, 2009
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999